# Institutional investment in healthcare companies

> Live situation record from CLSTR: https://clstr.news/situations/institutional-investment-in-healthcare-companies
> Updated: 2026-08-19T08:02:39.000Z. Sources: 3. Developments: 2.

Recent SEC filings indicate varied institutional investment activity across several medical and pharmaceutical companies during the second quarter.

In the medical technology sector, Stryker Corporation experienced shifts in ownership. Argent Trust Co increased its stake by 66.4%, while AMG National Trust Bank and Janney Montgomery Scott LLC reduced their respective holdings by 17.7% and 17.6%. New positions were also established by several other firms, contributing to a total institutional ownership of approximately 77.09%.

In the healthcare and pharmaceutical sectors, Zimmer Biomet Holdings, Inc. and Vertex Pharmaceuticals saw significant interest. First National Bank of Omaha and DCF Advisers LLC acquired substantial shares in Zimmer Biomet. Similarly, Vertex Pharmaceuticals saw new or increased positions from E Fund Management Co. Ltd., DCF Advisers LLC, Knuff & Co LLC, and NewEdge Wealth LLC.

## Timeline

### 2026-08-19: Institutional investors increase stakes in Zimmer Biomet and Vertex Pharmaceuticals

Institutional investors have significantly increased their stakes in Zimmer Biomet and Vertex Pharmaceuticals, according to recent SEC filings detailing multi-million dollar acquisitions.

2 sources. https://clstr.news/cluster/institutional-investors-increase-stakes-in-zimmer-biomet-and-vertex-pharmaceuticals

### 2026-08-16: Stryker Corporation sees shifts in institutional ownership

Institutional investors are shifting positions in Stryker Corporation, with Argent Trust Co increasing its stake by 66.4% while AMG National Trust Bank and Janney Montgomery Scott LLC reduced their holdings.

3 sources. https://clstr.news/cluster/stryker-corporation-sees-shifts-in-institutional-ownership

---
Cite as: Institutional investment in healthcare companies. CLSTR, https://clstr.news/situations/institutional-investment-in-healthcare-companies
